Acknowledgement
This work was supported by the 2023 education, research and student guidance grant funded by Jeju National University.
References
- Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012;64:3452-62. https://doi.org/10.1002/art.34562
- Watts RA, Hatemi G, Burns JC, Mohammad AJ. Global epidemiology of vasculitis. Nat Rev Rheumatol 2022;18:22-34. https://doi.org/10.1038/s41584-021-00718-8
- Tabakovic D, Smith R, Jayne D, Mohammad AJ. High risk of stroke in ANCA-associated vasculitis-a population-based study. Rheumatology (Oxford) 2023;62:2806-12. https://doi.org/10.1093/rheumatology/keac669
- Mourguet M, Chauveau D, Faguer S, Ruidavets JB, Bejot Y, Ribes D, et al. Increased ischemic stroke, acute coronary artery disease and mortality in patients with granulomatosis with polyangiitis and microscopic polyangiitis. J Autoimmun 2019;96:134-41. https://doi.org/10.1016/j.jaut.2018.09.004
- Berti A, Matteson EL, Crowson CS, Specks U, Cornec D. Risk of cardiovascular disease and venous thromboembolism among patients with incident ANCA-associated vasculitis: a 20-year population-based cohort study. Mayo Clin Proc 2018;93:597-606. https://doi.org/10.1016/j.mayocp.2018.02.010
- Zheng Y, Zhang Y, Cai M, Lai N, Chen Z, Ding M. Central nervous system involvement in ANCA-associated vasculitis: what neurologists need to know. Front Neurol 2019;9:1166.
- Terrier B, Chironi G, Pagnoux C, Cohen P, Puechal X, Simon A, et al. Factors associated with major cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study. J Rheumatol 2014;41:723-9. https://doi.org/10.3899/jrheum.130882
- Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, et al. Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011;70:488-94. https://doi.org/10.1136/ard.2010.137778
- Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, et al. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2013;65:2441-9. https://doi.org/10.1002/art.38044
- Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Toumelin PL, et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011;90:19-27. https://doi.org/10.1097/MD.0b013e318205a4c6